Skip to content

Corporate divestitures, week of 2 to 8 November 2026

Completed sales and spin-offs of business units disclosed in SEC 8-K filings during the week of 2 to 8 November 2026 (Monday to Sunday, by filing date). Every row links to its filing.

8
Divestitures
4
With a disclosed value
$1.48bn
Disclosed value
0
Spin-offs
Week of 2 to 8 November 2026

Every completed divestiture filed this week.

FiledSellerBusiness soldBuyerDisclosed valueSeller sectorFiling
2026-11-06Kontoor Brands, Inc. (KTB)Lee business
What the filing says

"EX-99.1 2 exhibit991-projectstormclo.htm EX-99.1 Document Exhibit 99.1 KONTOOR BRANDS COMPLETES THE SALE OF THE LEE BUSINESS TO AUTHENTIC BRANDS GROUP GREENSBORO, N.C. - November 3 2026 - Kontoor Brands, Inc. (NYSE KTB) today announced it has completed the sale of the Lee business to Authentic Brands Group"

On the price: "Pursuant to the terms and subject to the conditions set forth in the Purchase Agreement, the Company agreed to sell to the Buyer all outstanding shares of Lee capital stock for an aggregate purchase price of $750.0 million in cash, subject to certain adjustments, including for cash, indebtedness, and net working capital."

Authentic Brands Group$750MConsumer and retailSEC 8-K exhibit
2026-11-02TripAdvisor, Inc. (TRIP)TheFork (online restaurant reservation and management platform in Europe)
What the filing says

"On November 1, 2026, Tripadvisor, Inc., a Nevada corporation (the " Company "), consummated the sale of the legal entities comprising the Company's online restaurant reservation and management platform in Europe known as "TheFork" (the " Business ") to American Express Travel Related Services Company, Inc., a New York corporation (" Buyer "), pursuant to the Equity Purchase Agreement entered into on August 2, 2026 (the " Equity Purchase Agreement ")."

On the price: "Under the terms of the Equity Purchase Agreement, Buyer acquired the Business for $700 million, subject to certain adjustments, in an all-cash transaction (the " Transaction ")."

American Express Travel Related Services Company, Inc.$700MTechnologySEC 8-K
2026-11-05Inogen Inc (INGN)U.S. oxygen rental business
What the filing says

"On November 2, 2026, Inogen, Inc. ("Inogen" or the "Company") completed the previously announced sale of the United States oxygen rental business (the "Rental Business") to Rotech Healthcare Inc. ("Rotech"), pursuant to the terms of the Asset Purchase Agreement, dated as of September 29, 2026 (the "Asset Purchase Agreement")."

On the price: "The aggregate purchase price is estimated at up to approximately $24.8 million based on the inventory and patient records to be transferred and is subject to post-closing reconciliation, and payable in six installments."

Rotech Healthcare Inc.$24.8MHealthcareSEC 8-K
2026-11-05PSQ Holdings, Inc. (PSQH)EveryLife (direct-to-consumer diaper and baby products brand)
What the filing says

"On November 5, 2026 (the "Closing Date"), PSQ Holdings, Inc. (the "Company"), through its wholly owned subsidiaries EveryLife, Inc. and EveryLife Women, LLC ("EveryLife"), completed the sale (the "Transaction") of certain of the Company's assets that comprise EveryLife, a direct-to-consumer diaper and baby products brand, to FreeHold Brands, LLC, a Wyoming limited liability company ("Buyer"), pursuant to an Asset Purchase Agreement, dated July 28, 2025 (as amended, the "Purchase Agreement"), by and between EveryLife and Buyer."

On the price: "On the Closing Date, EveryLife and Buyer entered into a second amendment to the Purchase Agreement (the "Second Amendment") providing for an adjustment to the purchase price, pursuant to which the Company received $1.0 million in cash and a $4.5 million seller note issued by the Buyer (the "Seller Note")."

FreeHold Brands, LLC$5.5MBusiness servicesSEC 8-K
2026-11-02Equitable Holdings, Inc. (EQH)Employee Benefits business
What the filing says

"On October 13th, the Company completed the sale of its Employee Benefits business to The Hartford"

The HartfordNot disclosedFinancialsSEC 8-K exhibit
2026-11-02Theriva Biologics, Inc. (TOVX)antibiotic-degrading enzyme portfolio (SYN-004 ribaxamase, SYN-007 and SYN-006 assets)
What the filing says

"On October 30, 2026 (the "Effective Date"), Theriva Biologics, Inc. (the "Company") entered into an Asset Purchase and Sale Agreement (the "Purchase Agreement") with Biossil Labs Inc., a corporation organized under the laws of Canada (the "Biossil"), pursuant to which the Company sold to Biossil, and Biossil purchased from the Company, the Company's assets exclusively relating to SYN-004 (ribaxamase), the Company's oral β-lactamase product candidate, including its improvements, modifications and reformulations, including SYN-007 (collectively, "Ribaxamase"), as well as certain assets exclusively related to SYN-006, the Company's carbapenemase product candidate (collectively, the "Purchased Assets")."

On the price: "In consideration for the Purchased Assets, Biossil paid the Company an upfront payment of $350,000 at the Closing, which is non-refundable and non-creditable against other amounts payable under the Purchase Agreement."

Biossil Labs Inc.Not disclosedHealthcareSEC 8-K
2026-11-05LIGHTPATH TECHNOLOGIES INC (LPTH)LightPath (Zhenjiang) Optical Instrumentation Co., Ltd. (China operations)
What the filing says

"LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced that effective on October 30, 2026, it closed the previously announced sale of its wholly owned subsidiary, LightPath (Zhenjiang) Optical Instrumentation Co., Ltd. ("LPOIZ"), including its manufacturing facility and operations in China, to an entity owned by members of LPOIZ's incumbent management ..."

Not named in this filingNot disclosedTechnologySEC 8-K exhibit
2026-11-05BENTLEY SYSTEMS INC (BSY)Cohesive (IBM Maximo implementation and consulting services business)
What the filing says

"On October 13, 2026, we completed the divestiture of Cohesive-a business that provides IBM Maximo-related implementation and consulting services and operated separately from our infrastructure engineering software offerings-by contributing it to Naviam, a leading IBM Maximo partner."

NaviamNot disclosedTechnologySEC 8-K exhibit

127 candidate filings read; data built 2026-11-10. 5 more from filings the search could not classify, such as quarterly results releases, read by hand. Values are as stated in the filing, before adjustments.

Corrections

Rows removed or changed after this week was first published, each checked by hand against its filing on 13 November 2026.

  • Corrected: Kontoor Brands, Inc., Lee business (8-K filed 2026-11-06). Stated value added: $750M; closing date added: November 2, 2026. Stated aggregate purchase price and closing date from the pro forma exhibit in the same filing. SEC filing
  • Removed: CARDINAL HEALTH INC, Outcomes business (8-K filed 2026-11-05). Outcomes was an equity-method investment (a minority stake), and the earnings release gives no closing date. SEC filing
  • Removed: ELUTIA INC., SimpliDerm business (8-K filed 2026-11-05). Earnings-release recap of the SimpliDerm sale closed on August 17, 2026, already in the tracker for 2026-08 (8-K filed 2026-08-21). SEC filing
  • Corrected: LIGHTPATH TECHNOLOGIES INC, LightPath (Zhenjiang) Optical Instrumentation Co., Ltd. (China operations) (8-K filed 2026-11-05). Description corrected; closing date added: October 30, 2026. Unit ran on into the press-release subhead; the buyer is an unnamed entity owned by local management. SEC filing
  • Removed: RADIAN GROUP INC, Real Estate Services business (8-K filed 2026-11-05). Earnings-release recap of the Real Estate Services sale completed in August 2026, already in the tracker for 2026-08 (filed 2026-08-06). SEC filing
  • Removed: SPACCircle Acquisition Corp., 266,590 Private Placement Units at a price of $10.00 per Private Placement Unit (8-K filed 2026-11-03). A blank-check company selling private placement units to its sponsor: a securities sale, not a business. SEC filing
  • Corrected: Equitable Holdings, Inc., Employee Benefits business (8-K filed 2026-11-02). Buyer changed from "Hartford" to "The Hartford"; closing date added: October 13, 2026. Buyer named in full; closing date from the evidence sentence. SEC filing
By seller sector

Week of 2 to 8 November 2026 by sector.

Seller sectorDivestituresWith a disclosed valueDisclosed value
Technology31$700M
Healthcare21$24.8M
Consumer and retail11$750M
Business services11$5.5M
Financials10$0
Carve-out alerts for buyers

The week's carve-outs in your sectors, every Wednesday.

One email a week with the completed divestitures and spin-offs from SEC 8-K filings that match your sectors and deal size, each with the filing. A private page holds the full history with a CSV. From $1,500 a year.

See the alert feed
For acquirers

Looking to buy carve-outs?

Register your thesis: sectors, size and geography. When a divestiture mandate we take to market fits it, a senior advisor on our team contacts you under NDA. No fee.

Register your thesis
Method

What counts, and where it comes from.

A row is a completed sale or spin-off of a business unit (a business, segment, division or named subsidiary) reported in a Form 8-K filed with the SEC during the month (or, on a weekly page, the ISO week, Monday to Sunday): under Item 2.01, completion of acquisition or disposition of assets, or in a press release attached to the filing that says the sale has closed.

Sales of buildings, loan books or securities are left out, as is the sale of a whole company. Seller, buyer and value come from the filing, and each row keeps a sentence from it and a link to it. Where a filing does not name the buyer or the price, the table says so rather than filling the gap. The sector is the seller's SEC industry code, not the unit's; where the seller has none (a private or foreign parent, named in a filing made by the buyer), it is the sector of the business sold.

Weekly pages start in September 2026. The months from January 2025 to April 2026, and some deals in later months, were added in October 2026 from every Item 2.01 filing in that window, read and classified by hand rather than by the weekly search. Deals a seller reported only in a quarterly results release or another press release were read and added by hand as well.

Source: SEC EDGAR full-text search and the filings themselves. Public filings only. None of these transactions is one of our mandates, and nothing here is advice.

Planning a carve-out of your own?

The filings show what closed. The work that decides the price happens months earlier: the perimeter, the standalone numbers and the transition services.

Confidential inquiry

Every mandate startswith one conversation.

Tell us what you are considering. A senior advisor on our team will come back with a straight read on value, timing and who would actually buy it, before you commit to anything.

  • Confidential. Nothing you share leaves the advisory team.
  • Success-based. No retainer, no upfront fees, no obligation.
  • A senior advisor on our team responds within one business day.

We never sell or rent lists, and we do not add you to a marketing list without asking. With your consent we pass your enquiry to the team that will handle it.